Image -
ALP-2301-4.jpg
MS-based HCP analysis is already being used in the development of all types of biologics including the new mRNA vaccines and cell and gene therapies targeting an array of diseases, such as diabetes, Parkinson’s, and AIDS. According to Bryant McLaughlin, an experienced CMC executive in the biopharmaceutical industry, this analytical method is a huge benefit. Photo: Alphalyse A/S
go to media item
- License:
- Media Use
The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
- File format:
- .jpg
- Size:
- 3000 x 2000, 741 KB
